Clinical trial
A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS
NCT00967785 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 6, 2010
- Completion date
- June 25, 2026
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infections, leukopenia, myelokathexis, neutropenia, warts